event tracking

Parkinson’s Disease

162 results.

VAI DEFAULT HEADER
August 7, 2016 New model recreates early spread of Parkinson’s disease in the brain

GRAND RAPIDS, Mich. (Aug. 8, 2016)—They’re two of the biggest mysteries in Parkinson’s disease research—where does the disease start? And how can it be stopped…

July 26, 2016 Indicators of Parkinson’s disease risk found in unexpected places

GRAND RAPIDS, Mich. (July 27, 2016)—Clues that point toward new risk mechanisms for developing Parkinson’s disease are hiding in some unusual spots, according to

VAI DEFAULT HEADER
July 11, 2016 Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease

Note: To read the commentary published in the Journal of Parkinson's Disease click here. Investigators will focus on safety for long-term use in non-cancer…

June 13, 2016 Lessons from lactose intolerance: Investigating epigenomic aging

New insights into lactose intolerance may give scientists more than a better understanding of why some people lose the ability to digest…

May 23, 2016 Explaining the epigenome: An interview with Dr. Viviane Labrie (part two)

Dr. Viviane Labrie is an assistant professor in Van Andel Research Institute’s Center for Neurodegenerative Science. Her area of expertise is the…

May 16, 2016 Explaining the epigenome: An interview with Dr. Viviane Labrie (part one)

Dr. Viviane Labrie is an assistant professor in Van Andel Research Institute’s Center for Neurodegenerative Science. Her area of expertise is the…

April 26, 2016 Founder of movement disorders field to receive Parkinson’s award

 Stanley Fahn, M.D., honored by Van Andel Institute GRAND RAPIDS, Mich. (April 27, 2016)—In honor of his immeasurable contributions to the study and treatment of movements…

April 3, 2016 Changing the course: Parkinson’s disease research in 2016

By Patrik Brundin, M.D., Ph.D. Director, Center for Neurodegenerative Science The time has come to shift the paradigm on Parkinson’s disease. Never before have we…